
### [NCIT:C9152](http://purl.obolibrary.org/obo/NCIT_C9152)
**Label:** Superficial Spreading Melanoma

**Subclasses:** [NCIT:C8790](http://purl.obolibrary.org/obo/NCIT_C8790) (Stage I Superficial Spreading Melanoma AJCC v7), [NCIT:C8793](http://purl.obolibrary.org/obo/NCIT_C8793) (Stage IV Superficial Spreading Melanoma AJCC v6 and v7), [NCIT:C8791](http://purl.obolibrary.org/obo/NCIT_C8791) (Stage II Superficial Spreading Melanoma AJCC v6 and v7), [NCIT:C8792](http://purl.obolibrary.org/obo/NCIT_C8792) (Stage III Superficial Spreading Melanoma AJCC v7), 

**Class expressions from DL-Learner:**

- [NCIT:C62342](http://purl.obolibrary.org/obo/NCIT_C62342) (Melanoma Cell with Large Nucleus and Abundant Pale Cytoplasm) 60.00%
- [NCIT:C18363](http://purl.obolibrary.org/obo/NCIT_C18363) (BRAF Gene) 60.00%
- Thing 51.82%
- [NCIT:C62400](http://purl.obolibrary.org/obo/NCIT_C62400) (Large Melanoma Cell) 45.36%
- [NCIT:C62400](http://purl.obolibrary.org/obo/NCIT_C62400) (Large Melanoma Cell) and (not ([NCIT:C39901](http://purl.obolibrary.org/obo/NCIT_C39901) (Prostatic Duct Urothelial Carcinoma))) 45.36%
- [NCIT:C62400](http://purl.obolibrary.org/obo/NCIT_C62400) (Large Melanoma Cell) and (not ([NCIT:C39899](http://purl.obolibrary.org/obo/NCIT_C39899) (Secondary Prostate Urothelial Carcinoma))) 45.36%
- [NCIT:C62400](http://purl.obolibrary.org/obo/NCIT_C62400) (Large Melanoma Cell) and (not ([NCIT:C39897](http://purl.obolibrary.org/obo/NCIT_C39897) (Prostate Ductal Adenocarcinoma, Solid Pattern))) 45.36%
- [NCIT:C62400](http://purl.obolibrary.org/obo/NCIT_C62400) (Large Melanoma Cell) and (not ([NCIT:C39896](http://purl.obolibrary.org/obo/NCIT_C39896) (Prostate Ductal Adenocarcinoma, Papillary Pattern))) 45.36%
- [NCIT:C62400](http://purl.obolibrary.org/obo/NCIT_C62400) (Large Melanoma Cell) and (not ([NCIT:C39895](http://purl.obolibrary.org/obo/NCIT_C39895) (Prostate Ductal Adenocarcinoma, Cribriform Pattern))) 45.36%
- [NCIT:C62400](http://purl.obolibrary.org/obo/NCIT_C62400) (Large Melanoma Cell) and (not ([NCIT:C3989](http://purl.obolibrary.org/obo/NCIT_C3989) (Parathyroid Hyperplasia))) 45.36%
- [NCIT:C62400](http://purl.obolibrary.org/obo/NCIT_C62400) (Large Melanoma Cell) and (not ([NCIT:C39885](http://purl.obolibrary.org/obo/NCIT_C39885) (Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant))) 45.36%
- [NCIT:C62400](http://purl.obolibrary.org/obo/NCIT_C62400) (Large Melanoma Cell) and (not ([NCIT:C39880](http://purl.obolibrary.org/obo/NCIT_C39880) (Acinar Prostate Adenocarcinoma, Atrophic Variant))) 45.36%
- [NCIT:C62400](http://purl.obolibrary.org/obo/NCIT_C62400) (Large Melanoma Cell) and (not ([NCIT:C39875](http://purl.obolibrary.org/obo/NCIT_C39875) (Loss of Chromosome 9q))) 45.36%
- [NCIT:C62400](http://purl.obolibrary.org/obo/NCIT_C62400) (Large Melanoma Cell) and (not ([NCIT:C39874](http://purl.obolibrary.org/obo/NCIT_C39874) (Urethral Verrucous Carcinoma))) 45.36%
- [NCIT:C62400](http://purl.obolibrary.org/obo/NCIT_C62400) (Large Melanoma Cell) and (not ([NCIT:C39873](http://purl.obolibrary.org/obo/NCIT_C39873) (Urethral Glandular Metaplasia))) 45.36%


